Cite
HARVARD Citation
O'Reilly, E. et al. (2017). Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab‐Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results. Oncologist. pp. 1429-e139. [Online].